Multiple-Dose Study in Healthy Participants Under Fasting Conditions to Evaluate the Bioequivalence of One Film-Coated Mini-Tablet of Indapamide SR 1.5 mg versus One Film-Coated Tablet of Indapamide SR 1.5 mg and to Compare the Bioavailability of One Film-Coated Mini-Tablet of Indapamide SR 1.5 mg versus One Film-Coated Tablet of Indapamide IR 2.5 mg.
Phase 4 – monitoring after market approval
Conditions:
No medical condition.
Sponsor: Institut De Recherches Internationales Servier IRIS
trial.available_in:
БГ
Overview
Trial status: Authorised
Who can participate
Age group: 18-64 years
Gender: Female, Male
Target enrollment: 48 participants
БГ